1. ALLA AKTIER
  2. NYHETER
  3. BACTIGUARD

Bactiguard

Nyheter Bactiguard Nyheter alla bolag
Affiliate
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

Bactiguard Holding AB’s Annual and Sustainability Report 2025

REG

The Annual and Sustainability Report 2025 for Bactiguard Holding AB (publ) is now available at ir.bactiguard.com/

During 2025, we built a stronger foundation by sharpening our focus as a licensing company, strengthening existing partnerships, and solidifying our therapeutic areas where our coating technology can address significant unmet needs in medical device-related infections. While positioning ourselves to deliver our 2030 targets, we also improved profitability, driven by a disciplined approach to costs, while creating a solid base for sustainable growth.

“Our existing license partnerships remain the backbone of our business. Together with our partners, we strengthened collaboration through enhanced ways of working and the achievement of important milestones for Bactiguard-coated products.” Christine Lind comments in her CEO statement.

Read more in Bactiguard Holding AB’s Annual and Sustainability Report 2025 here

For further information, please contact:
Patrick Bach, CFO +46 761 295 911

About Bactiguard
Bactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas where infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access.

Bactiguard operates through license partnerships with leading global MedTech companies that apply the technology to their medical devices. The company also has a portfolio of wound management products. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine. Bactiguard is headquartered in Stockholm and is listed on Nasdaq Stockholm and is included in the Small-Cap segment.

Read more about Bactiguard: www.bactiguard.com
Follow Bactiguard on LinkedIn

This information is information that Bactiguard Holding is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-04-16 07:00 CEST.

Image Attachments
Bactiguard Holding AB’s Annual and Sustainability Report 2025 Cover

Attachments
Bactiguard Holding ABs Annual And Sustainability Report 2025

Datum 2026-04-16, kl 07:00
Källa MFN
Bifogade filer
Bactiguard Holding ABs Annual And Sustainability Report 2025
Bactiguard Holding AB’s Annual and Sustainability Report 2025 Cover